Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOUND: Regorafenib in Metastatic Solid Tumors After Progression on Standard Therapy
2014-001093-34Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in Metastatic solid neoplasm, sponsored by Humanitas Research Hospital. Started Sep 2014; status: completed.
02
Drugs
regorafenib
03
Conditions
Metastatic solid neoplasm
Beyond the preview
Go deeper on 2014-001093-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001093-34.